{"name":"Università degli Studi di Brescia","slug":"universit-degli-studi-di-brescia","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"mixture of amino and keto acids","genericName":"mixture of amino and keto acids","slug":"mixture-of-amino-and-keto-acids","indication":"Other","status":"marketed"},{"name":"Dinoprostone vaginal pessary","genericName":"Dinoprostone vaginal pessary","slug":"dinoprostone-vaginal-pessary","indication":"Cervical ripening and labor induction in pregnant women at or near term","status":"marketed"},{"name":"Nepafenac 0.1% eyedrops","genericName":"Nepafenac 0.1% eyedrops","slug":"nepafenac-0-1-eyedrops","indication":"Other","status":"marketed"},{"name":"formoterol - beclometasone","genericName":"formoterol - beclometasone","slug":"formoterol-beclometasone","indication":"Other","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Indomethacin 0.5% eyedrops","genericName":"Indomethacin 0.5% eyedrops","slug":"indomethacin-0-5-eyedrops","indication":"Postoperative ocular inflammation and pain following cataract surgery","status":"phase_3"},{"name":"Ketorolac 0.5% eyedrops","genericName":"Ketorolac 0.5% eyedrops","slug":"ketorolac-0-5-eyedrops","indication":"Postoperative ocular pain and inflammation following cataract surgery","status":"phase_3"},{"name":"Pranoprofen Eyedrops","genericName":"Pranoprofen Eyedrops","slug":"pranoprofen-eyedrops","indication":"Postoperative inflammation and pain following ocular surgery","status":"marketed"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Salmeterol Fluticasone","genericName":"Salmeterol Fluticasone","slug":"salmeterol-fluticasone","indication":"Asthma maintenance therapy","status":"marketed"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Bromfenac 0.09% eyedrops","genericName":"Bromfenac 0.09% eyedrops","slug":"bromfenac-0-09-eyedrops","indication":"Postoperative inflammation and pain following ocular surgery","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Ketorolac + Ranibizumab","genericName":"Ketorolac + Ranibizumab","slug":"ketorolac-ranibizumab","indication":"Age-related macular degeneration (AMD)","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Omega-3 Supplementation","genericName":"Omega-3 Supplementation","slug":"omega-3-supplementation","indication":"Hypertriglyceridemia","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"rare","drugs":[{"name":"n-3 PUFAs","genericName":"n-3 PUFAs","slug":"n-3-pufas","indication":"Hypertriglyceridemia","status":"phase_3"}]}],"pipeline":[{"name":"Indomethacin 0.5% eyedrops","genericName":"Indomethacin 0.5% eyedrops","slug":"indomethacin-0-5-eyedrops","phase":"phase_3","mechanism":"Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation in the eye.","indications":["Postoperative ocular inflammation and pain following cataract surgery","Seasonal allergic conjunctivitis","Corneal refractive surgery-related inflammation"],"catalyst":""},{"name":"Ketorolac 0.5% eyedrops","genericName":"Ketorolac 0.5% eyedrops","slug":"ketorolac-0-5-eyedrops","phase":"phase_3","mechanism":"Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and thereby decrease inflammation and pain in the eye.","indications":["Postoperative ocular pain and inflammation following cataract surgery","Seasonal allergic conjunctivitis","Ocular pain associated with corneal abrasion or refractive surgery"],"catalyst":""},{"name":"Pranoprofen Eyedrops","genericName":"Pranoprofen Eyedrops","slug":"pranoprofen-eyedrops","phase":"marketed","mechanism":"Pranoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes to reduce prostaglandin synthesis and inflammation in the eye.","indications":["Postoperative inflammation and pain following ocular surgery","Allergic conjunctivitis","Seasonal allergic rhinoconjunctivitis"],"catalyst":""},{"name":"Salmeterol Fluticasone","genericName":"Salmeterol Fluticasone","slug":"salmeterol-fluticasone","phase":"marketed","mechanism":"Salmeterol/fluticasone is a combination inhaled corticosteroid and long-acting beta-2 agonist that reduces airway inflammation and dilates airways to improve breathing.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"mixture of amino and keto acids","genericName":"mixture of amino and keto acids","slug":"mixture-of-amino-and-keto-acids","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Bromfenac 0.09% eyedrops","genericName":"Bromfenac 0.09% eyedrops","slug":"bromfenac-0-09-eyedrops","phase":"phase_3","mechanism":"Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation in the eye.","indications":["Postoperative inflammation and pain following ocular surgery","Ocular inflammation associated with allergic conjunctivitis or other inflammatory eye conditions"],"catalyst":""},{"name":"Dinoprostone vaginal pessary","genericName":"Dinoprostone vaginal pessary","slug":"dinoprostone-vaginal-pessary","phase":"marketed","mechanism":"Dinoprostone is a prostaglandin F2α analog that binds to prostaglandin receptors on the uterus to stimulate myometrial contractions and promote cervical ripening and labor induction.","indications":["Cervical ripening and labor induction in pregnant women at or near term","Management of incomplete abortion or miscarriage"],"catalyst":""},{"name":"Ketorolac + Ranibizumab","genericName":"Ketorolac + Ranibizumab","slug":"ketorolac-ranibizumab","phase":"marketed","mechanism":"Ketorolac reduces ocular inflammation via COX inhibition while ranibizumab blocks VEGF-A to inhibit pathological neovascularization in the eye.","indications":["Age-related macular degeneration (AMD)","Diabetic macular edema (DME)","Retinal vein occlusion (RVO)"],"catalyst":""},{"name":"Nepafenac 0.1% eyedrops","genericName":"Nepafenac 0.1% eyedrops","slug":"nepafenac-0-1-eyedrops","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Omega-3 Supplementation","genericName":"Omega-3 Supplementation","slug":"omega-3-supplementation","phase":"marketed","mechanism":"Omega-3 fatty acids reduce triglycerides and modulate inflammatory pathways by competing with arachidonic acid metabolism and inhibiting pro-inflammatory eicosanoid production.","indications":["Hypertriglyceridemia","Cardiovascular disease prevention","Rheumatoid arthritis","Inflammatory bowel disease"],"catalyst":""},{"name":"formoterol - beclometasone","genericName":"formoterol - beclometasone","slug":"formoterol-beclometasone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"n-3 PUFAs","genericName":"n-3 PUFAs","slug":"n-3-pufas","phase":"phase_3","mechanism":"n-3 PUFAs are a class of fatty acids that exert anti-inflammatory effects and improve cardiovascular health.","indications":["Hypertriglyceridemia","Cardiovascular disease prevention"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":12,"phaseCounts":{"phase_3":4,"marketed":8},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}